NCT01062867View on ClinicalTrials.gov

First Administration to Man Of Org 25435 a New Intravenous Anesthetic

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

March 31, 2000

Study Completion Date

March 31, 2000

Conditions
Anaesthesia
Interventions
DRUG

ORG25435

Intended doses: 0.25, 0.5, 1.0, 2.0, 3.0, 4.0, 5.0 and 6.0 mg/kg by intravenous infusion over 1 min Up to 25mg/kg by infusion over 30min

Trial Locations (2)

Unknown

Phase 1 Clinical Trials, Plymouth

Phase 1 Clinical Trials Ltd, Plymouth

Sponsors

Collaborators (1)

Veeda Clinical Research
All Listed Sponsors
collaborator

Veeda Clinical Research

INDUSTRY

collaborator

Organon Teknika

UNKNOWN

lead

University of Plymouth

OTHER

NCT01062867 - First Administration to Man Of Org 25435 a New Intravenous Anesthetic | Biotech Hunter | Biotech Hunter